Lilly To Pay $13M, Cap Insulin Cost In Deal Worth Up To $500M
Insulin buyers asked a New Jersey federal judge Friday to greenlight a class settlement with Eli Lilly & Co. resolving claims it schemed to drive up insulin drug prices, a deal...To view the full article, register now.
Already a subscriber? Click here to view full article